Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia

NCT01546415 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Overload

Interventions

DRUG: Desferasirox

Sponsor

Novartis Pharmaceuticals